CD169<sup>+</sup> macrophages orchestrate plasmacytoid dendritic cell arrest and retention for optimal priming in the bone marrow of malaria-infected mice.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36278864.
- Also identified by DOI 10.7554/eLife.78873 and PMC identifier 9648966.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Plasmacytoid dendritic cells (pDCs) are the most potent producer of type I interferon (IFN), but how pDC is primed in vivo is poorly defined. Using a mouse model of severe malaria, we have previously established that upon priming by CD169<sup>+</sup> macrophages (MPs), pDC initiates type I IFN-I secretion in the bone marrow (BM) of infected mice via cell-intrinsic TLR7 sensing and cell-extrinsic STING sensing. Herein we show that CD169<sup>+</sup> MP and TLR7 sensing are both required for pDC arrest during priming, suggesting CD169<sup>+</sup> MP are the source of TLR7 ligands. We establish that TLR7 sensing in pDC and chemotaxis are both required for pDC arrest and functional communication with CD169<sup>+</sup> MP in the BM. Lastly, we demonstrate that STING sensing in CD169<sup>+</sup> MP control pDC initiation of type I IFN production while also regulating pDC clustering and retention/egress from the BM. Collectively, these results link pDC acquisition of type I IFN-secreting capacity with changes in their motility, homing and interactions with CD169<sup>+</sup> MP during infection. Thus, targeting this cellular interaction may help modulate type I IFN to improve outcomes of microbial infections and autoimmune diseases.
Medical subject headings
- Bone Marrow
- Dendritic Cells
- Macrophages
- Malaria
- Toll-Like Receptor 7